Study assessing ruxolitinib for the management of severe pneumonia caused by SARS-CoV-2,exploring the combination with dexamethasone
Latest Information Update: 08 Feb 2022
At a glance
- Drugs Ruxolitinib (Primary) ; Dexamethasone
- Indications COVID 2019 infections; COVID-19 pneumonia
- Focus Therapeutic Use
Most Recent Events
- 08 Feb 2022 New trial record